Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Research in Pharmacogenomics and Accurate Medication of New Antiplatelet Drug Ticagrelor

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03161002
Recruitment Status : Recruiting
First Posted : May 19, 2017
Last Update Posted : May 15, 2019
Sponsor:
Information provided by (Responsible Party):
Cui Yimin, Peking University First Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : September 2019
  Estimated Study Completion Date : December 2019